|
RAB2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58349999779261E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59939958446864E-10 |
| Normal-vs-Stage2 |
4.783000E-03 |
| Normal-vs-Stage3 |
1.460790E-01 |
| Normal-vs-Stage4 |
2.758400E-02 |
| Stage1-vs-Stage2 |
2.405000E-01 |
| Stage1-vs-Stage3 |
2.249900E-02 |
| Stage1-vs-Stage4 |
7.288600E-01 |
| Stage2-vs-Stage3 |
4.491400E-01 |
| Stage2-vs-Stage4 |
5.855200E-01 |
| Stage3-vs-Stage4 |
3.264000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.78179981458993E-10 |
| Normal-vs-AfricanAmerican |
1.82650000002393E-06 |
| Normal-vs-Asian |
7.812400E-01 |
| Caucasian-vs-AfricanAmerican |
7.284200E-01 |
| Caucasian-vs-Asian |
1.810800E-01 |
| AfricanAmerican-vs-Asian |
4.434400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.14774897655934E-12 |
| Normal-vs-Female |
8.113700E-02 |
| Male-vs-Female |
1.91459999998589E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.29030000001396E-06 |
| Normal-vs-Extreme_Weight |
3.11169978672865E-10 |
| Normal-vs-Obese |
3.566900E-04 |
| Normal-vs-Extreme_Obese |
8.279600E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.982200E-01 |
| Normal_Weight-vs-Obese |
1.501410E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.209000E-01 |
| Extreme_Weight-vs-Obese |
2.256100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.388000E-01 |
| Obese-vs-Extreme_Obese |
2.199000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.032000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.26560000035525E-07 |
| Normal-vs-Age(61-80Yrs) |
2.07979966582172E-10 |
| Normal-vs-Age(81-100Yrs) |
2.86090000001238E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.310970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.650000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.736000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.615380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.367200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.43418610321078E-12 |
| Normal-VS-Type2 PRCC |
3.559000E-04 |
| Normal-VS-KIRP CIMP |
4.135800E-01 |
| Normal-VS-Unclassified PRCC |
2.602200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.303100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.26540000000708E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.558100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.630370E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.017400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.586000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54649999994927E-06 |
| Normal-vs-N1 |
4.037600E-01 |
| Normal-vs-N2 |
3.388000E-01 |
| N0-vs-N1 |
1.449880E-02 |
| N0-vs-N2 |
6.320200E-01 |
| N1-vs-N2 |
5.086600E-01 |
|
|
